Trial intelligence / Profile preview

Eliquis in isolated calf vein thrombosis

NCT03590743Phase 4Terminated

Sponsor
Mayo Clinic
Start
Feb 2019
Primary completion
Jun 2019
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of apixaban in deep vein thrombosis (DVT), sponsored by Mayo Clinic. Started Feb 2019; status: terminated.

02

Drugs

apixaban
03

Conditions

deep vein thrombosis (DVT)

Beyond the preview

Go deeper on NCT03590743.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03590743.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call